#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital hypotransferrinaemia Osteosarcoma metastatic Follicle centre lymphoma follicular grade I, II – III Hypomagnesaemia Hyperinsulinism Vitamin B12 deficiency Philadelphia positive chronic myeloid leukaemia Skin cancer Medullary thyroid cancer Anal cancer recurrent Squamous cell carcinoma of the vulva Endometrial adenocarcinoma Infertility male Immunodeficiency common variable Hydrocephalus More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome with excess blasts Hepatic angiosarcoma – Trials in Disease Hypereosinophilic syndrome – Diagnostics Congenital nephrogenic diabetes insipidus – Basic Information Primary mediastinal large B-cell lymphoma Familial amyotrophic lateral sclerosis – Trials in Disease Krabbe’s disease – Treatment Krabbe’s disease – Diagnostics Sarcoma Small intestine leiomyosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tomligisiran Citicoline Sodium Molgramostim Avacopan Goserelin Acetate Vidutolimod Aticaprant Agomelatine HEMOPEXIN, HUMAN Bms-986458 Cemiplimab Lacutamab Ivosidenib RO7268489 Apalutamide Defactinib Zoledronic Acid Abc-23B-116 Rituximab ANXV More therapies…

    Learn about Your Condition

    Childhood asthma Nasopharyngeal cancer Bronchopulmonary aspergillosis Chordoma Cluster headache Melanoma recurrent Cortisol abnormal Cervical dysplasia Agitation postoperative Staphylococcal infection Neuroendocrine carcinoma Breast neoplasm Hyperlipidaemia Oesophageal carcinoma Acute leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Using Nicotine Electronic Cigarettes and Varenicline for Smoking Cessation in Smokers of 10+ Cigarettes Daily

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Varenicline
    France

  • Study of Bemarituzumab with Irinotecan, Paclitaxel, Ramucirumab, or Trifluridine/Tipiracil for Advanced Stomach or Gastroesophageal Cancer in Patients After Chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Bemarituzumab
    • Tipiracil Hydrochloride
    • Trifluridine
    Germany Spain

  • Study on Gene Therapy for Patients with RAG1-Deficient Severe Combined Immunodeficiency Using RAG1-LV-CD34+ Cells

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Autologous haematopoietic stem cell transplant
    Italy The Netherlands Poland Spain

  • Study on the Safety and Effectiveness of Peginterferon Alfa-2a and Ruxolitinib for Newly Diagnosed Polycythemia Vera Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Polycythaemia vera
    Investigated Drugs:
    • Peginterferon Alfa-2A
    • Ruxolitinib
    Denmark

  • Study on the Treatment of Warthin’s Tumor with Bleomycin Sclerotherapy for Patients with Warthin’s Tumor

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Papillary cystadenoma lymphomatosum
    Investigated Drugs:
    • Bleomycin Sulfate Ph. Eur.
    Finland

  • Study on the Effects of T89 and Glyceryl Trinitrate for Patients with Stable Angina

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Angina pectoris
    Investigated Drugs:
    • Glyceryl Trinitrate
    • T89
    Bulgaria Poland Romania Slovakia
Previous Page
1 … 859 860 861 862 863 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!